Procainamide hydrochloride NEW
| Price | $59 | $138 |
| Package | 100mg | 500mg |
| Supply Ability: | 10g |
| Update Time: | 2026-04-22 |
Product Details
| Product Name: Procainamide hydrochloride | CAS No.: 614-39-1 |
| Purity: 99.83% | Supply Ability: 10g |
| Release date: 2026/04/22 |
Product Introduction
Bioactivity
| Name | Procainamide hydrochloride |
| Description | Procainamide Hydrochloride (Procapan) is the hydrochloride salt form of procainamide, an amide derivative exhibiting class 1A antiarrhythmic property and analog of procaine. Procainamide hydrochloride reversibly binds to and blocks activated (open) voltage-gated sodium channels, thereby blocks the influx of sodium ions into the cell, which leads to an increase in threshold for excitation and inhibit depolarization during phase 0 of the action potential. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2.5 mg/mL (9.2 mM), Sonication is recommended. DMSO : 45 mg/mL (165.57 mM), Sonication is recommended. H2O : 183.97 mM, Sonication is recommended. |
| Keywords | SodiumChannel | Sodium Channel | Procainamide Hydrochloride | Procainamide | Inhibitor | inhibit | DNAMethyltransferase | DNA Methyltransferase | DNA (cytosine-5)-methyltransferase 1 | Autophagy | AChR |
| Inhibitors Related | Stavudine | Aceglutamide | Hemin | Tamoxifen | Cysteamine hydrochloride | Guanidine hydrochloride | Hydroxychloroquine | Paeonol | Naringin | N,N-Dicyclohexylcarbodiimide | Alginic acid | Sildenafil citrate |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Pain-Related Compound Library | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Anti-Viral Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $138.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-04-22 | |
| $10.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2026-03-20 | ||
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2025-12-01 | ||
|
Hebei Yanxi Chemical Co., Ltd.
|
2025-06-20 | |||
| $59.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-05-02 | |
| $1.00 |
Apeloa production Co.,Limited
|
2025-02-13 | ||
| $8.00 |
Wuhan Boyuan Import & Export Co., LTD
|
2024-01-08 | ||
| $80.00 |
Weijer International Trade (Hebei) Co., Ltd
|
2023-08-16 | ||
| $50.00 |
Henan Bao Enluo International TradeCo.，LTD
|
2023-07-26 | ||
| $100.00 |
Hebei baicao biology science and technology co., ltd
|
2023-02-13 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY